Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.
2.

Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.

Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, Forland F, Rossi R, Callens S, Vanden Broeck D.

PLoS One. 2016 Oct 20;11(10):e0163965. doi: 10.1371/journal.pone.0163965. eCollection 2016. Review.

3.

The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.

Unruh ML, Larive B, Eggers PW, Garg AX, Gassman JJ, Finkelstein FO, Kimmel PL, Chertow GM; FHN Trial Group.

Nephrol Dial Transplant. 2016 Jun;31(6):984-91. doi: 10.1093/ndt/gfw062. Epub 2016 Apr 15.

4.

The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.

Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW; Frequent Hemodialysis Network (FHN) Trial Group.

Blood Purif. 2016;41(4):277-86. doi: 10.1159/000441966. Epub 2016 Jan 21.

5.

Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.

Ferrario M, Raimann JG, Larive B, Pierratos A, Thijssen S, Rajagopalan S, Greene T, Cerutti S, Beck G, Chan C, Kotanko P; Frequent Hemodialysis Network (FHN) Trial Group.

Blood Purif. 2015;40(1):99-108. doi: 10.1159/000381665. Epub 2015 Jul 4.

7.

Increases in heroin overdose deaths - 28 States, 2010 to 2012.

Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, Davis JW, Dudek J, Eichler BA, Fernandes JC, Fondario A, Gabella B, Hume B, Huntamer T, Kariisa M, Largo TW, Miles J, Newmyer A, Nitcheva D, Perez BE, Proescholdbell SK, Sabel JC, Skiba J, Slavova S, Stone K, Tharp JM, Wendling T, Wright D, Zehner AM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 3;63(39):849-54.

8.

Short- and long-term effects of ambient ozone and fine particulate matter on the respiratory health of chronic obstructive pulmonary disease subjects.

Kariisa M, Foraker R, Pennell M, Buckley T, Diaz P, Criner GJ, Wilkins JR 3rd.

Arch Environ Occup Health. 2015;70(1):56-62. doi: 10.1080/19338244.2014.932753.

PMID:
25136856
9.

Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.

Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, Tarallo M, Finkelstein FO, Kimmel PL; FHN Trials Group.

Am J Kidney Dis. 2013 May;61(5):748-58. doi: 10.1053/j.ajkd.2012.11.047. Epub 2013 Jan 15.

10.

Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW; Frequent Hemodialysis Network Trials Group.

J Nephrol. 2012 May-Jun;25(3):302-9. doi: 10.5301/jn.5000160.

PMID:
22505248
11.

The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.

Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM; FHN Trial Group.

Kidney Int. 2012 Jul;82(1):90-9. doi: 10.1038/ki.2012.75. Epub 2012 Mar 28.

12.

Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2012 May;7(5):782-94. doi: 10.2215/CJN.10601011. Epub 2012 Mar 15.

13.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

14.

Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):101-12. doi: 10.1053/j.ajkd.2010.08.021.

15.

Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):90-100. doi: 10.1053/j.ajkd.2010.08.024. Epub 2010 Nov 30.

16.

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS.

N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

17.

Initial feasibility of a multi-station high resolution three-dimensional dark blood angiography protocol for the assessment of peripheral arterial disease.

Mihai G, Chung YC, Kariisa M, Raman SV, Simonetti OP, Rajagopalan S.

J Magn Reson Imaging. 2009 Oct;30(4):785-93. doi: 10.1002/jmri.21923.

PMID:
19787730
18.

Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance.

Sanz J, Kariisa M, Dellegrottaglie S, Prat-González S, Garcia MJ, Fuster V, Rajagopalan S.

JACC Cardiovasc Imaging. 2009 Mar;2(3):286-95. doi: 10.1016/j.jcmg.2008.08.007.

19.

Solute clearances and fluid removal in the frequent hemodialysis network trials.

Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M; Frequent Hemodialysis Network Study Group; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health.

Am J Kidney Dis. 2009 May;53(5):835-44. doi: 10.1053/j.ajkd.2008.12.039. Epub 2009 Apr 1.

PMID:
19339093
20.

Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O'Donnell TP, Mehta D, Fuster V, Rajagopalan S.

Am J Cardiol. 2007 Aug 15;100(4):731-5. Epub 2007 Jun 27.

PMID:
17697838

Supplemental Content

Loading ...
Support Center